Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Tables)

v3.23.3
Loss Per Share (Tables)
3 Months Ended
Sep. 30, 2023
Loss Per Share [Abstract]  
Schedule of Common Stock Equivalents The Company had the following common stock equivalents at September 30, 2023 and 2022:
    September 30,
2023
    September 30,
2022
 
Convertible Notes     9,341,825       9,341,825  
Options     3,123,137       3,012,639  
Warrants    
      41,103  
Total     12,464,962       12,395,567